Leads, implantable devices

 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and CRT-D), in the United States and Canada. The system...

Lumax 740 DX system

The U.S. Food and Drug Administration (FDA) granted final approval for the Biotronik Lumax 740 DX system. The device is a first-in-class implantable cardiac defibrillator (ICD) that utilizes a single lead with atrial sensi...

subcutaneous implantable cardioverter defibrillator, S-ICD

The U.S. Food and Drug Administration (FDA) has granted Boston Scientific Corp. regulatory approval for its S-ICD System, the world's first commercially available subcutaneous ...

August 3, 2012 — St. Jude Medical recently announced initial findings from the Riata lead evaluation study. The study’s phase I results found that externalized conductors occurred in 9.3 percent of the smaller-diameter Riata ST 7 French leads...

The Population Health Research Institute (PHRI) has conducted a further independent analysis of data received from ongoing prospective registries that monitor...
St. Jude Medical Inc., a global medical device company, has announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to...
St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This...
 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy...
Lumax 740 DX system, ICD
The Biotronik Lumax 740 DX system is a first-in-class implantable cardiac defibrillator (ICD) that utilizes a single lead
Zoll Medical Corp.'s U.S. Food and Drug Administration (FDA)-cleared OneStep pediatric CPR electrodes are the first...
The S-ICD System is the world's first subcutaneous implantable cardioverter defibrillator (S-ICD) for the treatment of patients at risk for...
Sorin Group announced U.S. Food and Drug Administration (FDA) approval and commercial launch in May 2012 for a full portfolio of pacing,...

Articles

 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy...
The S-ICD System is the world's first subcutaneous implantable defibrilator
The U.S. Food and Drug Administration (FDA) has granted Boston Scientific Corp. regulatory approval for its S-ICD System, the world's first commercially...
The gloves are off and the fight has begun between St. Jude Medical and Medtronic over clinical data regarding their implantable cardioverter...
April 6, 2012 — St. Jude Medical announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of...

Video Center

Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 2 days ago
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 4 days ago
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 2 days ago
EP lab, Tom De potter, depotter, angiography dose reduction
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...